New 2025 data reveals a rapid influx of IMGs and U.S.-trained doctors entering practice—but matching this growth to patient needs remains the ultimate challenge.
That information could be reassuring or terrifying, but for now it’s a potential tool to speed drug development by helping to identify and enroll high-risk people into studies of possible Alzheimer’s treatments or preventive strategies.
The move aligns with the advice of many online influencers and podcasters, including men’s health gurus who tout the hormone as a way to boost muscle and energy.
Dr. Melissa Yuan-Innes reflects on the tragedy of patients who choose to put their faith in unproven ‘natural’ treatments over evidence-based medicine.
